US 12,358,928 B2
Compounds, compositions and methods
Anthony A. Estrada, San Mateo, CA (US); Jianwen A. Feng, San Mateo, CA (US); Brian Fox, Brisbane, CA (US); Colin Phillip Leslie, Pozzolengo (IT); Joseph P. Lyssikatos, South San Francisco, CA (US); Alfonso Pozzan, Monticello Conte Otto (IT); Zachary K. Sweeney, Redwood City, CA (US); and Javier de Vicente Fidalgo, Foster City, CA (US)
Assigned to Denali Therapeutics Inc., South San Francisco, CA (US)
Filed by Denali Therapeutics Inc., South San Francisco, CA (US)
Filed on Aug. 10, 2023, as Appl. No. 18/232,435.
Application 17/185,684 is a division of application No. 16/782,446, filed on Feb. 5, 2020, abandoned.
Application 16/782,446 is a division of application No. 16/130,817, filed on Sep. 13, 2018, granted, now 10,604,535, issued on Mar. 31, 2020.
Application 16/130,817 is a division of application No. 15/721,470, filed on Sep. 29, 2017, granted, now 10,131,676, issued on Nov. 20, 2018.
Application 15/721,470 is a division of application No. 15/424,216, filed on Feb. 3, 2017, granted, now 9,815,850, issued on Nov. 14, 2017.
Application 18/232,435 is a continuation of application No. 17/185,684, filed on Feb. 25, 2021, abandoned.
Claims priority of provisional application 62/292,202, filed on Feb. 5, 2016.
Claims priority of provisional application 62/341,019, filed on May 24, 2016.
Claims priority of provisional application 62/363,775, filed on Jul. 18, 2016.
Claims priority of provisional application 62/385,217, filed on Sep. 8, 2016.
Claims priority of provisional application 62/417,219, filed on Nov. 3, 2016.
Prior Publication US 2024/0150376 A1, May 9, 2024
Int. Cl. C07D 471/12 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); C07D 261/18 (2006.01); C07D 267/14 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 491/048 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01); C07D 498/14 (2006.01); C07D 513/04 (2006.01)
CPC C07D 513/04 (2013.01) [C07D 261/18 (2013.01); C07D 267/14 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); C07D 498/04 (2013.01); C07D 498/14 (2013.01)] 8 Claims
 
1. A compound, or a pharmaceutically acceptable salt, tautomer, stereoisomer or mixture of stereoisomers thereof, that is chosen from:
 
No. Structure
 
 38A
 

OG Complex Work Unit Chemistry
 
 38B
 

OG Complex Work Unit Chemistry
 
200
 

OG Complex Work Unit Chemistry